Hin Sang Group (International)'s (HKG:6893) loss widened to HK$49.4 million in the year ended March 31 from HK$36.7 million in fiscal 2024, according to an annual report filed Thursday with the Hong Kong bourse.
Loss per share at the healthcare and household products company widened to HK$0.0452 from HK$0.0336 in the previous fiscal year.
Revenue slipped 0.8% to HK$91.9 million from HK$92.6 million a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.